-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation